My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
2023-015 - Resolution Approving the Texas Term Sheet for the Texas Opiod Settlement Allocation and Indiviudal Approval of Subdivisions Participation
City-of-Paris
>
City Clerk
>
Resolutions
>
2023
>
2023-015 - Resolution Approving the Texas Term Sheet for the Texas Opiod Settlement Allocation and Indiviudal Approval of Subdivisions Participation
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
4/18/2023 9:06:03 AM
Creation date
3/14/2023 11:23:13 AM
Metadata
Fields
Template:
CITY CLERK
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
58
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
1. Increase availability and distribution of naloxone and other drugs that treat <br />overdoses for first responders, overdose patients, opioid users, families and <br />friends of opioid users, schools, community navigators and outreach workers, <br />drug offenders upon release from jail/prison, or other members of the general <br />public. <br />Public health entities provide free naloxone and training to anyone in the <br />community. <br />3. Training and education regarding naloxone and other drugs that treat overdoses <br />for first responders, overdose patients, patients taking opioids, families, schools, <br />and other members of the general public. <br />4. Enable school nurses and other school staff to respond to opioid overdoses, and <br />provide them with naloxone, training, and support. <br />5. Expand, improve, or develop data tracking software and applications for <br />overdoses/naloxone revivals. <br />6. Public education relating to emergency responses to overdoses <br />7. Public education relating to immunity and Good Samaritan laws. <br />8. Educate first responders regarding the existence and operation of immunity and <br />Good Samaritan laws. <br />9. Syringe service programs and other evidence -informed programs to reduce <br />harms associated with intravenous drug use, including supplies, staffing, space, <br />peer support services, referrals to treatment, connections to care, and the full <br />range of harm reduction and treatment services provided by these programs. <br />10. Expand access to testing and treatment for infectious diseases such as HIV and <br />Hepatitis C resulting from intravenous opioid use. <br />11. Support mobile units that offer or provide referrals to harm reduction services, <br />treatment, recovery supports, health care, or other appropriate services to <br />persons that use opioids or persons with OUD and any co-occurring SUD/MH <br />issues. <br />12. Provide training in harm reduction strategies to health care providers, students, <br />peer recovery coaches, recovery outreach specialists, or other professionals that <br />provide care to persons who use opioids or persons with OUD and any co- <br />occurring SUD/MH issues. <br />10 <br />
The URL can be used to link to this page
Your browser does not support the video tag.